Company: KAVL
Filing Date: 2025-08-18
Form Type: 424B5
Source: 0001731122-25-001141
Chunk: 16

Company: Kaival Brands Innovations Group, Inc.
Filing Date: 2025-08-18
Form: 424B5
Chunk 16
---
 in resales of our common stock by our current stockholders concerned about
the potential dilution of their holdings. In turn, these resales could have the effect of depressing the market price for our common stock.

The actual number of shares we will issue under the Sales Agreement, at any one time or in total, is uncertain.

Subject to certain limitations in the Sales Agreement with the Sales Agent and
compliance with applicable law, we have the discretion to deliver placement notices to the Sales Agent at any time throughout the term
of the Sales Agreement. The number of shares that are sold by the Sales Agent after delivering a placement notice will fluctuate based
on the market price of the common stock during the sales period, the limits we set with the Sales Agent, in any applicable placement notice,
and the demand for our common stock during the sales period. Because the price of each share sold will fluctuate during the sales period,
it is not currently possible to predict the number of shares of common stock that will ultimately be issued by us under the Sales Agreement
or aggregate proceeds to be raised in connection with those sales.

<div align='center'>8</div>

The shares of common stock offered under this prospectus supplement and accompanying base prospectus will be sold in “at the market offerings,” and investors who buy shares at different times will likely pay different prices.

Investors who purchase shares under this prospectus
supplement and accompanying base prospectus at different times will likely pay different prices, and so may experience different outcomes
in their investment results. We will have discretion, subject to market demand, to vary the timing, prices, and numbers of shares sold,
and there is no minimum or maximum sales price. Investors may experience declines in the value of their shares as a result of share sales
made at prices lower than the prices they paid.

We may not be able to maintain the listing of our common stock on Nasdaq, which could adversely affect our liquidity and the trading volume and market price of our common stock and decrease or eliminate your investment.

Nasdaq requires listing issuers to comply with certain
standards in order to remain listed on its exchange. If, for any reason, Nasdaq should delist our securities from trading on its exchange
and we are unable to obtain listing on another reputable national securities exchange, a reduction in some or all of the following may
occur, each of which could materially adversely affect our stockholders.

On April 3, 2025, we received a letter from Nasdaq
not